The effect of cyclosporine on the development and expression of cannabinoid tolerance in mice

Pharmacology Biochemistry and Behavior

Volumn 82, Issue 4, 2005, Pages 658-663

  Banafshe, Hamid R ^a   Ghazi Khansari, Mahmoud ^a   Dehpour, Ahmad R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cannabinoid; Cyclosporine; Mice; Tolerance

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR; CYCLOSPORIN;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CANNABINOIDS; CATALEPSY; CYCLOSPORINE; DRUG TOLERANCE; MALE; MICE; MORPHOLINES; NAPHTHALENES;

ANIMALIA;

EID: 31844443181     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.11.006     Document Type: Article

References (32)

1. H.N. Bhargava The effects of thyrotropin releasing hormone and histidyl-proline diketopiperazine on delta-9-tetrahydrocannabinol-induced hypothermia Life Sci 26 11 1980 845 850
2. H.N. Bhargava, and G.A. Matwyshyn Influence of thyrotropin releasing hormone and histidyl-proline diketopiperazine on spontaneous locomotor activity and analgesia induced by delta 9-tetrahydrocannabinol in the mouse Eur J Pharmacol 68 2 1980 147 154
3. 9-THC in the mouse Psychopharmacology 57 1978 234 248
4. F.E. D'Amour, and D.L. Smith A method for determining loss of pain sensation J Pharmacol 72 1941 74 79
5. T.M. Dawson, J.P. Steiner, V.L. Dawson, J.L. Dinerman, G.R. Uhl, and S.H. Snyder Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protect against glutamate neurotoxicity Proc Natl Acad Sci U S A 90 1993 9808 9812
6. J.A. Dill, and A.C. Howlett Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs J Pharmacol Exp Ther 244 3 1988 1157 1163
7. S. Ejtemaei Mehr, M. Samini, K. Namiranian, H. Homayoun, S.A. Gaskari, and A.R. Dehpour Inhibition by immunophilin ligands of morphin-induced tolerance and dependence in guinea pig ileum Eur J Pharmacol 467 2003 205 210
8. F. Fan, Q. Tao, M. Abood, and B.R. Martin Cannabinoid receptor down regulation of the inhibitory effect CP 55,940 on a adenylyl cyclase in the cerberllum Brain Res 706 1996 13 20
9. R.E. Handschumacher, M.W. Harding, J. Rice, R.J. Drugge, and D.W. Speicher Cyclophilin: a specific cytosolic binding protein for cyclosporin A Science 226 4674 1984 544 547
10. D. Holtzman, R.A. Bowell, J.H. Jafee, and D.X. Freeman Delta-9-tetrahydrocannabinol neurochemical and behavioral effects in the rat Science 163 1969 1464 1467
11. H. Homayoun, S. Khavandgar, K. Namiranian, and A.R. Dehpour The effect of cyclosporin A on morphine tolerance and dependence: involvement of nitric oxide pathway Eur J Pharmacol 452 2002 67 75
12. H. Homayoun, S. Khavandgar, S.E. Mehr, K. Namiranian, and A.R. Dehpour The effects of FK506 on the development and expression of morphine tolerance and dependence in mice Behav Pharmacol 14 2 2003 121 127
13. B.R. Martin Cellular effects of cannabinoids Pharmacol Rev 38 1986 45 74
14. H.M. Ockenfels, S.N. Wagner, P. Oeljeklaus, B. Schneck, G. Nussbaum, and K.H. Jakobs Inhibition of T cell cAMP formation by cyclosporin A and FK506 Naunyn-Schmiedeberg's Arch Pharmacol 353 5 1996 513 516
15. H.M. Ockenfels, G. Nussbaum, B. Schneck, S.N. Wagner, E. Haen, and M. Goos The effect of cyclosporin A and FK 506 on the cAMP content in psoriatic keratinocytes Skin Pharmacol 9 4 1996 281 288
16. R.G. Pertwee The ring test: a quantitative method for assessing the cataleptic effect of cannabis in mice Br J Pharmacol 46 1972 753 763
17. R.G. Pertwee The central neuropharmacology of neurotropic cannabinoids Pharmacol Ther 36 1988 189 261
18. M.R. Rao, V.K. Kanji, M.K. Salahudeen, C. Wang, and V. Sekhar Inhibition of rat brain nitric oxide synthase activity by cyclosporin-A Indian J Exp Biol 34 12 1996 1265 1267
19. M. Rhee, I. Nevo, T. Avidor-resis, R. Levy, and Z. Vogel Differential superactivation of adenylyl cyclase isozyme after chronic activation of CB1 receptor Mol Pharmacol 57 2000 746 752
20. T. Rubino, D. Vigano', P. Massi, M. Spinello, E. Zagato, and G. Giagnoni Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions Neuropharmacology 39 7 2000 1331 1336
21. F. Ruiz, G. Alvarez, M. Ramos, M. Hernandez, E. Bogonez, and J. Satrustegui Cyclosporin A targets involved in protection against glutamate excitotoxicity Eur J Pharmacol 404 1-2 2000 29 39
22. D.M. Sabatini, M.M. Lai, and S.H. Snyder Neural roles of immunophilins and their ligands Mol Neurobiol 15 1997 223 239
23. S.L. Schreiber, and G.R. Crabtree The mechanism of action of cyclosporin A and FK506 Immunol Today 13 4 1992 136 142
24. M. Shapira, M. Gafni, and Y. Sarne Long term interaction between opioid and cannabinoid agonists at the cellular level: cross-desensitization and down regulation Brain Res 960 2003 190 200
25. J. Sharkey, and S.P. Butcher Immunophilins mediate the immunoprotective effects of FK 506 in focal cerebral ischemia Nature 371 1994 336 339
26. E. Spina, A. Trovati, D. Parolaro, and G. Giagnoni A role of nitric oxide in WIN 55,212-2 tolerance in mice Eur J Pharmacol 343 2-3 1998 157 163
27. J.P. Steiner, T.M. Dawson, M. Fotuhi, C.E. Glatt, A.M. Snowmam, and N. Cohen High brain densities of immunophilin FKBP colocalized with calcineurin Nature 358 1992 584 587
28. J.P. Steiner, T.M. Dawson, and S.H. Synder Immunophilin: regulation of neurotransmitter release Mol Med 2 1996 325 333
29. S.H. Synder, T.M. Sabatini, M.M. Lai, J.P. Steiner, G.S. Hamilton, and P.D. Suzdac Neural action of immunophilin ligands Trends Pharmacol Sci 19 1998 21 26
30. S.N. Throat, and H.N. Bhargava Effect of NMDA receptor blockade and NOS inhibition on the acute and chronic action of THC in mice Brain Res 667 1 1994 77 82
31. V. Trajkovic, V. Jankovic, V. Badovinac, A. Mostrarcia, and M. Stojkovic Cyclosporin A inhibits activation of inducible NOS in C6 glioma cell line Brain Res 816 1999 92 98
32. M.J. Walker, and S.M. Huang Cannabinoid analgesia Pharmacol Ther 95 2002 127 135